nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—PTGS2—colon cancer	0.427	1	CbGaD
Dapsone—CYP3A7—Irinotecan—colon cancer	0.0548	0.13	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0548	0.13	CbGbCtD
Dapsone—CYP3A7—Vincristine—colon cancer	0.0479	0.114	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0479	0.114	CbGbCtD
Dapsone—CYP2C9—Capecitabine—colon cancer	0.0446	0.106	CbGbCtD
Dapsone—CYP3A5—Irinotecan—colon cancer	0.0411	0.0975	CbGbCtD
Dapsone—CYP2C8—Fluorouracil—colon cancer	0.0379	0.09	CbGbCtD
Dapsone—MPO—superior mesenteric artery—colon cancer	0.0373	0.383	CbGeAlD
Dapsone—CYP3A5—Vincristine—colon cancer	0.0359	0.0852	CbGbCtD
Dapsone—CYP2C9—Fluorouracil—colon cancer	0.0265	0.0628	CbGbCtD
Dapsone—CYP3A4—Irinotecan—colon cancer	0.016	0.038	CbGbCtD
Dapsone—CYP3A4—Vincristine—colon cancer	0.014	0.0332	CbGbCtD
Dapsone—Mafenide—CA7—colon cancer	0.00542	0.738	CrCbGaD
Dapsone—NAT2—renal system—colon cancer	0.00468	0.0482	CbGeAlD
Dapsone—Application site burn—Fluorouracil—colon cancer	0.00396	0.122	CcSEcCtD
Dapsone—MPO—endothelium—colon cancer	0.00337	0.0346	CbGeAlD
Dapsone—MPO—blood vessel—colon cancer	0.0031	0.0319	CbGeAlD
Dapsone—NAT2—liver—colon cancer	0.00286	0.0294	CbGeAlD
Dapsone—Localized exfoliation—Capecitabine—colon cancer	0.00215	0.0664	CcSEcCtD
Dapsone—Sulfanilamide—CA7—colon cancer	0.00192	0.262	CrCbGaD
Dapsone—Application site pain—Fluorouracil—colon cancer	0.00189	0.0582	CcSEcCtD
Dapsone—CYP2C18—digestive system—colon cancer	0.00181	0.0186	CbGeAlD
Dapsone—Application site reaction—Fluorouracil—colon cancer	0.00177	0.0545	CcSEcCtD
Dapsone—CYP2C18—vagina—colon cancer	0.0016	0.0165	CbGeAlD
Dapsone—PTGS1—endothelium—colon cancer	0.0016	0.0164	CbGeAlD
Dapsone—FMO3—vagina—colon cancer	0.00154	0.0158	CbGeAlD
Dapsone—PTGS2—endothelium—colon cancer	0.00153	0.0157	CbGeAlD
Dapsone—MPO—epithelium—colon cancer	0.00151	0.0155	CbGeAlD
Dapsone—PTGS1—blood vessel—colon cancer	0.00147	0.0151	CbGeAlD
Dapsone—PTGS2—blood vessel—colon cancer	0.00141	0.0145	CbGeAlD
Dapsone—MPO—renal system—colon cancer	0.0014	0.0144	CbGeAlD
Dapsone—CYP2C18—liver—colon cancer	0.00135	0.0139	CbGeAlD
Dapsone—PTGS2—gall bladder—colon cancer	0.00132	0.0136	CbGeAlD
Dapsone—FMO3—liver—colon cancer	0.0013	0.0134	CbGeAlD
Dapsone—CYP3A7—liver—colon cancer	0.00128	0.0132	CbGeAlD
Dapsone—Swelling face—Capecitabine—colon cancer	0.00122	0.0375	CcSEcCtD
Dapsone—MPO—lymphoid tissue—colon cancer	0.00116	0.012	CbGeAlD
Dapsone—MPO—digestive system—colon cancer	0.00115	0.0118	CbGeAlD
Dapsone—CYP3A7-CYP3A51P—liver—colon cancer	0.00109	0.0112	CbGeAlD
Dapsone—MPO—bone marrow—colon cancer	0.00106	0.0109	CbGeAlD
Dapsone—FMO3—lymph node—colon cancer	0.000996	0.0102	CbGeAlD
Dapsone—MPO—liver—colon cancer	0.000856	0.00881	CbGeAlD
Dapsone—PTGS2—embryo—colon cancer	0.00084	0.00864	CbGeAlD
Dapsone—CYP2C8—renal system—colon cancer	0.00082	0.00843	CbGeAlD
Dapsone—CYP2C19—digestive system—colon cancer	0.00077	0.00793	CbGeAlD
Dapsone—CYP3A5—renal system—colon cancer	0.00074	0.00761	CbGeAlD
Dapsone—PTGS1—epithelium—colon cancer	0.000717	0.00737	CbGeAlD
Dapsone—PTGS1—smooth muscle tissue—colon cancer	0.000691	0.00711	CbGeAlD
Dapsone—CYP2E1—renal system—colon cancer	0.00069	0.0071	CbGeAlD
Dapsone—PTGS2—epithelium—colon cancer	0.000685	0.00705	CbGeAlD
Dapsone—CYP2C19—vagina—colon cancer	0.00068	0.007	CbGeAlD
Dapsone—PTGS1—renal system—colon cancer	0.000665	0.00684	CbGeAlD
Dapsone—PTGS2—smooth muscle tissue—colon cancer	0.00066	0.00679	CbGeAlD
Dapsone—Proteinuria—Capecitabine—colon cancer	0.00066	0.0203	CcSEcCtD
Dapsone—MPO—lymph node—colon cancer	0.000657	0.00675	CbGeAlD
Dapsone—Protein urine present—Capecitabine—colon cancer	0.000651	0.0201	CcSEcCtD
Dapsone—PTGS2—renal system—colon cancer	0.000635	0.00654	CbGeAlD
Dapsone—CYP3A5—digestive system—colon cancer	0.000607	0.00624	CbGeAlD
Dapsone—CYP2C9—digestive system—colon cancer	0.000597	0.00615	CbGeAlD
Dapsone—CYP2C8—vagina—colon cancer	0.000594	0.00611	CbGeAlD
Dapsone—CYP2C19—liver—colon cancer	0.000574	0.0059	CbGeAlD
Dapsone—CYP2E1—lymphoid tissue—colon cancer	0.000573	0.0059	CbGeAlD
Dapsone—Muscular weakness—Vincristine—colon cancer	0.000569	0.0176	CcSEcCtD
Dapsone—CYP2E1—digestive system—colon cancer	0.000566	0.00582	CbGeAlD
Dapsone—CYP3A4—renal system—colon cancer	0.000555	0.00571	CbGeAlD
Dapsone—Skin exfoliation—Capecitabine—colon cancer	0.000553	0.0171	CcSEcCtD
Dapsone—PTGS1—digestive system—colon cancer	0.000545	0.00561	CbGeAlD
Dapsone—Nasopharyngitis—Fluorouracil—colon cancer	0.000538	0.0166	CcSEcCtD
Dapsone—CYP3A5—vagina—colon cancer	0.000536	0.00551	CbGeAlD
Dapsone—Pancreatitis—Irinotecan—colon cancer	0.000533	0.0164	CcSEcCtD
Dapsone—Muscular weakness—Fluorouracil—colon cancer	0.000531	0.0164	CcSEcCtD
Dapsone—PTGS2—lymphoid tissue—colon cancer	0.000528	0.00543	CbGeAlD
Dapsone—PTGS2—digestive system—colon cancer	0.000521	0.00536	CbGeAlD
Dapsone—Photosensitivity reaction—Vincristine—colon cancer	0.000509	0.0157	CcSEcCtD
Dapsone—CYP2C8—liver—colon cancer	0.000501	0.00515	CbGeAlD
Dapsone—Proteinuria—Methotrexate—colon cancer	0.000491	0.0151	CcSEcCtD
Dapsone—Neuropathy peripheral—Vincristine—colon cancer	0.000488	0.015	CcSEcCtD
Dapsone—Protein urine present—Methotrexate—colon cancer	0.000484	0.0149	CcSEcCtD
Dapsone—PTGS1—vagina—colon cancer	0.000482	0.00495	CbGeAlD
Dapsone—PTGS2—bone marrow—colon cancer	0.00048	0.00494	CbGeAlD
Dapsone—Photosensitivity reaction—Fluorouracil—colon cancer	0.000475	0.0146	CcSEcCtD
Dapsone—PTGS2—vagina—colon cancer	0.00046	0.00474	CbGeAlD
Dapsone—CYP3A4—digestive system—colon cancer	0.000455	0.00469	CbGeAlD
Dapsone—Neuropathy peripheral—Fluorouracil—colon cancer	0.000455	0.014	CcSEcCtD
Dapsone—CYP3A5—liver—colon cancer	0.000452	0.00465	CbGeAlD
Dapsone—CYP2C9—liver—colon cancer	0.000445	0.00458	CbGeAlD
Dapsone—Sinusitis—Fluorouracil—colon cancer	0.000435	0.0134	CcSEcCtD
Dapsone—CYP2E1—liver—colon cancer	0.000422	0.00434	CbGeAlD
Dapsone—Pharyngitis—Fluorouracil—colon cancer	0.000413	0.0127	CcSEcCtD
Dapsone—Skin exfoliation—Methotrexate—colon cancer	0.000412	0.0127	CcSEcCtD
Dapsone—PTGS2—liver—colon cancer	0.000388	0.00399	CbGeAlD
Dapsone—Nasopharyngitis—Capecitabine—colon cancer	0.000376	0.0116	CcSEcCtD
Dapsone—Muscular weakness—Capecitabine—colon cancer	0.000371	0.0114	CcSEcCtD
Dapsone—Influenza—Capecitabine—colon cancer	0.000364	0.0112	CcSEcCtD
Dapsone—Erythema—Fluorouracil—colon cancer	0.000363	0.0112	CcSEcCtD
Dapsone—Vertigo—Vincristine—colon cancer	0.000349	0.0108	CcSEcCtD
Dapsone—Vision blurred—Fluorouracil—colon cancer	0.000342	0.0105	CcSEcCtD
Dapsone—Vertigo—Irinotecan—colon cancer	0.00034	0.0105	CcSEcCtD
Dapsone—CYP3A4—liver—colon cancer	0.000339	0.00349	CbGeAlD
Dapsone—Photosensitivity reaction—Capecitabine—colon cancer	0.000332	0.0102	CcSEcCtD
Dapsone—Cough—Irinotecan—colon cancer	0.00033	0.0102	CcSEcCtD
Dapsone—Neuropathy peripheral—Capecitabine—colon cancer	0.000318	0.0098	CcSEcCtD
Dapsone—PTGS1—lymph node—colon cancer	0.000311	0.0032	CbGeAlD
Dapsone—PTGS2—lymph node—colon cancer	0.000298	0.00306	CbGeAlD
Dapsone—Pharyngitis—Capecitabine—colon cancer	0.000289	0.00891	CcSEcCtD
Dapsone—Tachycardia—Fluorouracil—colon cancer	0.000289	0.00891	CcSEcCtD
Dapsone—Insomnia—Vincristine—colon cancer	0.000287	0.00885	CcSEcCtD
Dapsone—Insomnia—Irinotecan—colon cancer	0.000279	0.00862	CcSEcCtD
Dapsone—Tinnitus—Capecitabine—colon cancer	0.000271	0.00837	CcSEcCtD
Dapsone—Insomnia—Fluorouracil—colon cancer	0.000268	0.00825	CcSEcCtD
Dapsone—Pancreatitis—Methotrexate—colon cancer	0.000265	0.00818	CcSEcCtD
Dapsone—Gastrointestinal pain—Vincristine—colon cancer	0.000259	0.008	CcSEcCtD
Dapsone—Erythema—Capecitabine—colon cancer	0.000253	0.00781	CcSEcCtD
Dapsone—Gastrointestinal pain—Irinotecan—colon cancer	0.000253	0.00779	CcSEcCtD
Dapsone—Abdominal pain—Vincristine—colon cancer	0.000251	0.00773	CcSEcCtD
Dapsone—Body temperature increased—Vincristine—colon cancer	0.000251	0.00773	CcSEcCtD
Dapsone—Photosensitivity reaction—Methotrexate—colon cancer	0.000247	0.00762	CcSEcCtD
Dapsone—Body temperature increased—Irinotecan—colon cancer	0.000244	0.00753	CcSEcCtD
Dapsone—Abdominal pain—Irinotecan—colon cancer	0.000244	0.00753	CcSEcCtD
Dapsone—Vision blurred—Capecitabine—colon cancer	0.000239	0.00736	CcSEcCtD
Dapsone—Body temperature increased—Fluorouracil—colon cancer	0.000234	0.00721	CcSEcCtD
Dapsone—Vertigo—Capecitabine—colon cancer	0.000228	0.00702	CcSEcCtD
Dapsone—Cough—Capecitabine—colon cancer	0.000221	0.00682	CcSEcCtD
Dapsone—Pharyngitis—Methotrexate—colon cancer	0.000215	0.00663	CcSEcCtD
Dapsone—Tinnitus—Methotrexate—colon cancer	0.000202	0.00623	CcSEcCtD
Dapsone—Tachycardia—Capecitabine—colon cancer	0.000202	0.00622	CcSEcCtD
Dapsone—Vomiting—Vincristine—colon cancer	0.000202	0.00622	CcSEcCtD
Dapsone—Headache—Vincristine—colon cancer	0.000199	0.00613	CcSEcCtD
Dapsone—Vomiting—Irinotecan—colon cancer	0.000196	0.00606	CcSEcCtD
Dapsone—Headache—Irinotecan—colon cancer	0.000194	0.00597	CcSEcCtD
Dapsone—Erythema—Methotrexate—colon cancer	0.000189	0.00582	CcSEcCtD
Dapsone—Nausea—Vincristine—colon cancer	0.000188	0.00581	CcSEcCtD
Dapsone—Vomiting—Fluorouracil—colon cancer	0.000188	0.0058	CcSEcCtD
Dapsone—Insomnia—Capecitabine—colon cancer	0.000187	0.00577	CcSEcCtD
Dapsone—CYP3A5—Irinotecan Pathway—APC—colon cancer	0.000187	0.0126	CbGpPWpGaD
Dapsone—Headache—Fluorouracil—colon cancer	0.000185	0.00572	CcSEcCtD
Dapsone—Nausea—Irinotecan—colon cancer	0.000184	0.00566	CcSEcCtD
Dapsone—CYP3A7—Metapathway biotransformation—CHST5—colon cancer	0.00018	0.0122	CbGpPWpGaD
Dapsone—Vision blurred—Methotrexate—colon cancer	0.000178	0.00548	CcSEcCtD
Dapsone—Nausea—Fluorouracil—colon cancer	0.000176	0.00542	CcSEcCtD
Dapsone—NAT2—Metabolism—CA7—colon cancer	0.000176	0.0119	CbGpPWpGaD
Dapsone—Vertigo—Methotrexate—colon cancer	0.000169	0.00523	CcSEcCtD
Dapsone—Gastrointestinal pain—Capecitabine—colon cancer	0.000169	0.00521	CcSEcCtD
Dapsone—Cough—Methotrexate—colon cancer	0.000165	0.00508	CcSEcCtD
Dapsone—Abdominal pain—Capecitabine—colon cancer	0.000163	0.00504	CcSEcCtD
Dapsone—Body temperature increased—Capecitabine—colon cancer	0.000163	0.00504	CcSEcCtD
Dapsone—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	0.000149	0.0101	CbGpPWpGaD
Dapsone—Insomnia—Methotrexate—colon cancer	0.000139	0.00429	CcSEcCtD
Dapsone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000134	0.00906	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000132	0.00891	CbGpPWpGaD
Dapsone—Vomiting—Capecitabine—colon cancer	0.000131	0.00405	CcSEcCtD
Dapsone—MPO—IL23-mediated signaling events—PIK3CA—colon cancer	0.000131	0.0089	CbGpPWpGaD
Dapsone—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.00013	0.00882	CbGpPWpGaD
Dapsone—CYP3A5—Metapathway biotransformation—CHST5—colon cancer	0.00013	0.0088	CbGpPWpGaD
Dapsone—Headache—Capecitabine—colon cancer	0.00013	0.00399	CcSEcCtD
Dapsone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000128	0.00865	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CA7—colon cancer	0.000127	0.00861	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Methotrexate—colon cancer	0.000126	0.00388	CcSEcCtD
Dapsone—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	0.000123	0.00837	CbGpPWpGaD
Dapsone—Nausea—Capecitabine—colon cancer	0.000123	0.00379	CcSEcCtD
Dapsone—Abdominal pain—Methotrexate—colon cancer	0.000122	0.00375	CcSEcCtD
Dapsone—Body temperature increased—Methotrexate—colon cancer	0.000122	0.00375	CcSEcCtD
Dapsone—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	0.000113	0.00762	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—PTGS2—colon cancer	0.000111	0.0075	CbGpPWpGaD
Dapsone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.000107	0.00724	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—PTGS2—colon cancer	0.000107	0.00723	CbGpPWpGaD
Dapsone—NAT2—Metabolism—CHST5—colon cancer	0.000106	0.00722	CbGpPWpGaD
Dapsone—NAT2—Metabolism—ODC1—colon cancer	0.000106	0.00722	CbGpPWpGaD
Dapsone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000103	0.007	CbGpPWpGaD
Dapsone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000103	0.007	CbGpPWpGaD
Dapsone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000103	0.00698	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.0001	0.00681	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—CCND1—colon cancer	0.0001	0.00678	CbGpPWpGaD
Dapsone—CYP2C18—FOXA1 transcription factor network—EP300—colon cancer	9.81e-05	0.00665	CbGpPWpGaD
Dapsone—Vomiting—Methotrexate—colon cancer	9.79e-05	0.00302	CcSEcCtD
Dapsone—MPO—C-MYB transcription factor network—CDKN1A—colon cancer	9.68e-05	0.00656	CbGpPWpGaD
Dapsone—Headache—Methotrexate—colon cancer	9.64e-05	0.00297	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	9.5e-05	0.00644	CbGpPWpGaD
Dapsone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	9.42e-05	0.00638	CbGpPWpGaD
Dapsone—PTGS2—S1P1 pathway—VEGFA—colon cancer	9.31e-05	0.00631	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—EP300—colon cancer	9.21e-05	0.00624	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	9.16e-05	0.00621	CbGpPWpGaD
Dapsone—Nausea—Methotrexate—colon cancer	9.14e-05	0.00282	CcSEcCtD
Dapsone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	8.97e-05	0.00608	CbGpPWpGaD
Dapsone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.88e-05	0.00601	CbGpPWpGaD
Dapsone—CYP3A4—Irinotecan Pathway—APC—colon cancer	8.68e-05	0.00588	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—NRAS—colon cancer	8.62e-05	0.00584	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—MYC—colon cancer	8.03e-05	0.00544	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—TP53—colon cancer	7.99e-05	0.00542	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CA7—colon cancer	7.74e-05	0.00524	CbGpPWpGaD
Dapsone—FMO3—Metabolism—ODC1—colon cancer	7.7e-05	0.00522	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CHST5—colon cancer	7.7e-05	0.00522	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—KRAS—colon cancer	7.42e-05	0.00502	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—colon cancer	6.93e-05	0.00469	CbGpPWpGaD
Dapsone—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	6.86e-05	0.00465	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—CASP3—colon cancer	6.53e-05	0.00443	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	6.49e-05	0.0044	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—HRAS—colon cancer	6.3e-05	0.00427	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—CTNNB1—colon cancer	6.3e-05	0.00427	CbGpPWpGaD
Dapsone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.24e-05	0.00423	CbGpPWpGaD
Dapsone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.21e-05	0.00421	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	6.04e-05	0.00409	CbGpPWpGaD
Dapsone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.92e-05	0.00401	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—EP300—colon cancer	5.85e-05	0.00397	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—VEGFA—colon cancer	5.54e-05	0.00376	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.46e-05	0.0037	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CA7—colon cancer	5.14e-05	0.00349	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	5.09e-05	0.00345	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	5.06e-05	0.00343	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CA7—colon cancer	4.99e-05	0.00338	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—EP300—colon cancer	4.84e-05	0.00328	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—SRC—colon cancer	4.71e-05	0.00319	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ODC1—colon cancer	4.69e-05	0.00318	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CHST5—colon cancer	4.69e-05	0.00318	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	4.59e-05	0.00311	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	4.53e-05	0.00307	CbGpPWpGaD
Dapsone—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	4.43e-05	0.003	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	4.37e-05	0.00296	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.36e-05	0.00296	CbGpPWpGaD
Dapsone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	4.31e-05	0.00292	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—MYC—colon cancer	4.22e-05	0.00286	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	4.13e-05	0.0028	CbGpPWpGaD
Dapsone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.12e-05	0.00279	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CA7—colon cancer	3.96e-05	0.00268	CbGpPWpGaD
Dapsone—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	3.96e-05	0.00268	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	3.9e-05	0.00264	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CA7—colon cancer	3.73e-05	0.00252	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CA7—colon cancer	3.72e-05	0.00252	CbGpPWpGaD
Dapsone—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	3.61e-05	0.00244	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	3.41e-05	0.00231	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.35e-05	0.00227	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.31e-05	0.00225	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—CCND1—colon cancer	3.25e-05	0.0022	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.22e-05	0.00218	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CA7—colon cancer	3.22e-05	0.00218	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—CDKN1A—colon cancer	3.14e-05	0.00213	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CHST5—colon cancer	3.12e-05	0.00211	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ODC1—colon cancer	3.12e-05	0.00211	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ODC1—colon cancer	3.02e-05	0.00205	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CHST5—colon cancer	3.02e-05	0.00205	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—EP300—colon cancer	2.99e-05	0.00203	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CA7—colon cancer	2.87e-05	0.00195	CbGpPWpGaD
Dapsone—PTGS2—Disease—LGR5—colon cancer	2.86e-05	0.00194	CbGpPWpGaD
Dapsone—PTGS2—Disease—CHST5—colon cancer	2.86e-05	0.00194	CbGpPWpGaD
Dapsone—NAT2—Metabolism—ABCB1—colon cancer	2.81e-05	0.00191	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	2.8e-05	0.0019	CbGpPWpGaD
Dapsone—NAT2—Metabolism—TYMS—colon cancer	2.76e-05	0.00187	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CA7—colon cancer	2.62e-05	0.00178	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—MYC—colon cancer	2.61e-05	0.00177	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CASP3—colon cancer	2.54e-05	0.00172	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CCND1—colon cancer	2.48e-05	0.00168	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.46e-05	0.00166	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	2.41e-05	0.00163	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CHST5—colon cancer	2.4e-05	0.00162	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ODC1—colon cancer	2.4e-05	0.00162	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ODC1—colon cancer	2.26e-05	0.00153	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CHST5—colon cancer	2.26e-05	0.00153	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ODC1—colon cancer	2.25e-05	0.00153	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CHST5—colon cancer	2.25e-05	0.00153	CbGpPWpGaD
Dapsone—PTGS2—Disease—AXIN2—colon cancer	2.06e-05	0.00139	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	2.05e-05	0.00139	CbGpPWpGaD
Dapsone—FMO3—Metabolism—ABCB1—colon cancer	2.03e-05	0.00138	CbGpPWpGaD
Dapsone—FMO3—Metabolism—TYMS—colon cancer	2e-05	0.00135	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—MYC—colon cancer	1.99e-05	0.00135	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	1.98e-05	0.00134	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PPARG—colon cancer	1.96e-05	0.00133	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CHST5—colon cancer	1.95e-05	0.00132	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ODC1—colon cancer	1.95e-05	0.00132	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—EGFR—colon cancer	1.94e-05	0.00132	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CHST5—colon cancer	1.74e-05	0.00118	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ODC1—colon cancer	1.74e-05	0.00118	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.73e-05	0.00117	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CA7—colon cancer	1.73e-05	0.00117	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.68e-05	0.00114	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.67e-05	0.00113	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TP53—colon cancer	1.63e-05	0.00111	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.63e-05	0.0011	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ODC1—colon cancer	1.59e-05	0.00108	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CHST5—colon cancer	1.59e-05	0.00108	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.55e-05	0.00105	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PTGS2—colon cancer	1.54e-05	0.00104	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.51e-05	0.00102	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.47e-05	0.000995	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PPARG—colon cancer	1.42e-05	0.000959	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.35e-05	0.000916	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.35e-05	0.000914	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.32e-05	0.000896	CbGpPWpGaD
Dapsone—NAT2—Metabolism—EP300—colon cancer	1.28e-05	0.000868	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.25e-05	0.000846	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.25e-05	0.000845	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ABCB1—colon cancer	1.24e-05	0.000839	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—TYMS—colon cancer	1.22e-05	0.000824	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.15e-05	0.000777	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PTGS2—colon cancer	1.11e-05	0.000754	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.11e-05	0.000752	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ODC1—colon cancer	1.05e-05	0.00071	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CHST5—colon cancer	1.05e-05	0.00071	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.9e-06	0.000671	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.81e-06	0.000665	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PIK3CA—colon cancer	9.47e-06	0.000642	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.37e-06	0.000635	CbGpPWpGaD
Dapsone—FMO3—Metabolism—EP300—colon cancer	9.26e-06	0.000627	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PPARG—colon cancer	8.62e-06	0.000584	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ABCB1—colon cancer	8.23e-06	0.000558	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.16e-06	0.000553	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—TYMS—colon cancer	8.09e-06	0.000548	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.05e-06	0.000546	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ABCB1—colon cancer	7.98e-06	0.000541	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—TYMS—colon cancer	7.84e-06	0.000531	CbGpPWpGaD
Dapsone—NAT2—Metabolism—AKT1—colon cancer	7.74e-06	0.000524	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.19e-06	0.000487	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PIK3CA—colon cancer	6.85e-06	0.000464	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTGS2—colon cancer	6.78e-06	0.000459	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.55e-06	0.000444	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.48e-06	0.000439	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ABCB1—colon cancer	6.34e-06	0.000429	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.34e-06	0.000429	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—TYMS—colon cancer	6.22e-06	0.000422	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.03e-06	0.000409	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ABCB1—colon cancer	5.96e-06	0.000404	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ABCB1—colon cancer	5.95e-06	0.000403	CbGpPWpGaD
Dapsone—PTGS2—Disease—FGFR3—colon cancer	5.94e-06	0.000403	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—TYMS—colon cancer	5.86e-06	0.000397	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—TYMS—colon cancer	5.85e-06	0.000396	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PPARG—colon cancer	5.73e-06	0.000388	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.65e-06	0.000383	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—EP300—colon cancer	5.64e-06	0.000382	CbGpPWpGaD
Dapsone—FMO3—Metabolism—AKT1—colon cancer	5.6e-06	0.000379	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PPARG—colon cancer	5.55e-06	0.000376	CbGpPWpGaD
Dapsone—PTGS2—Disease—APC—colon cancer	5.45e-06	0.00037	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.27e-06	0.000357	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.16e-06	0.000349	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ABCB1—colon cancer	5.16e-06	0.000349	CbGpPWpGaD
Dapsone—PTGS2—Disease—BRAF—colon cancer	5.13e-06	0.000347	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—TYMS—colon cancer	5.06e-06	0.000343	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.79e-06	0.000325	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.7e-06	0.000319	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ABCB1—colon cancer	4.6e-06	0.000312	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—TYMS—colon cancer	4.52e-06	0.000306	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTGS2—colon cancer	4.51e-06	0.000305	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PPARG—colon cancer	4.41e-06	0.000299	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTGS2—colon cancer	4.37e-06	0.000296	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.29e-06	0.000291	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ABCB1—colon cancer	4.2e-06	0.000284	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PIK3CA—colon cancer	4.17e-06	0.000283	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PPARG—colon cancer	4.15e-06	0.000281	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PPARG—colon cancer	4.14e-06	0.000281	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—TYMS—colon cancer	4.12e-06	0.000279	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.9e-06	0.000264	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—EP300—colon cancer	3.75e-06	0.000254	CbGpPWpGaD
Dapsone—PTGS2—Disease—CTNNB1—colon cancer	3.7e-06	0.000251	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—EP300—colon cancer	3.63e-06	0.000246	CbGpPWpGaD
Dapsone—PTGS2—Disease—CDKN1A—colon cancer	3.62e-06	0.000245	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PPARG—colon cancer	3.59e-06	0.000243	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.48e-06	0.000236	CbGpPWpGaD
Dapsone—PTGS2—Disease—EP300—colon cancer	3.44e-06	0.000233	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—AKT1—colon cancer	3.41e-06	0.000231	CbGpPWpGaD
Dapsone—PTGS2—Disease—SRC—colon cancer	3.35e-06	0.000227	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTGS2—colon cancer	3.26e-06	0.000221	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTGS2—colon cancer	3.26e-06	0.000221	CbGpPWpGaD
Dapsone—PTGS2—Disease—NRAS—colon cancer	3.22e-06	0.000218	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PPARG—colon cancer	3.2e-06	0.000217	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.17e-06	0.000215	CbGpPWpGaD
Dapsone—PTGS2—Disease—MYC—colon cancer	3e-06	0.000203	CbGpPWpGaD
Dapsone—PTGS2—Disease—TGFB1—colon cancer	2.99e-06	0.000203	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGFR—colon cancer	2.94e-06	0.000199	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PPARG—colon cancer	2.92e-06	0.000198	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—EP300—colon cancer	2.88e-06	0.000195	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTGS2—colon cancer	2.82e-06	0.000191	CbGpPWpGaD
Dapsone—PTGS2—Disease—KRAS—colon cancer	2.77e-06	0.000188	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CA—colon cancer	2.77e-06	0.000188	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ABCB1—colon cancer	2.77e-06	0.000188	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—TYMS—colon cancer	2.72e-06	0.000184	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—EP300—colon cancer	2.71e-06	0.000184	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—EP300—colon cancer	2.71e-06	0.000184	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CA—colon cancer	2.69e-06	0.000182	CbGpPWpGaD
Dapsone—PTGS2—Disease—PIK3CA—colon cancer	2.55e-06	0.000173	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTGS2—colon cancer	2.52e-06	0.000171	CbGpPWpGaD
Dapsone—PTGS2—Disease—HRAS—colon cancer	2.36e-06	0.00016	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—EP300—colon cancer	2.35e-06	0.000159	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTGS2—colon cancer	2.3e-06	0.000156	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—AKT1—colon cancer	2.26e-06	0.000153	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—AKT1—colon cancer	2.2e-06	0.000149	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CA—colon cancer	2.13e-06	0.000145	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—EP300—colon cancer	2.09e-06	0.000142	CbGpPWpGaD
Dapsone—PTGS2—Disease—AKT1—colon cancer	2.08e-06	0.000141	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CA—colon cancer	2.01e-06	0.000136	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CA—colon cancer	2e-06	0.000136	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PPARG—colon cancer	1.93e-06	0.00013	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—EP300—colon cancer	1.91e-06	0.000129	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—AKT1—colon cancer	1.74e-06	0.000118	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CA—colon cancer	1.74e-06	0.000118	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—AKT1—colon cancer	1.64e-06	0.000111	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—AKT1—colon cancer	1.64e-06	0.000111	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CA—colon cancer	1.55e-06	0.000105	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTGS2—colon cancer	1.51e-06	0.000103	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—AKT1—colon cancer	1.42e-06	9.61e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CA—colon cancer	1.41e-06	9.57e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—AKT1—colon cancer	1.27e-06	8.58e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—EP300—colon cancer	1.26e-06	8.54e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—AKT1—colon cancer	1.15e-06	7.82e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CA—colon cancer	9.32e-07	6.31e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—AKT1—colon cancer	7.61e-07	5.16e-05	CbGpPWpGaD
